You Searched For "moderna stock" and got 20 results
Sort By:
Moderna pops 17% after Merck exercises option to jointly develop a personalized cancer vaccine
The move is welcomed by investors because if successful, it would help Moderna diversify its revenu…
Matthew Fox
Moderna climbs as 4th-quarter sales blow past expectations and 2021 forecasts surge
The company during its earnings call also announced the September departure of Tal Zaks, its chief …
Max Adams
Moderna's billionaire CEO draws criticism for earning nearly $400 million in stock options last year, and then getting a raise on top of it
The exec donated $176 million after-tax to charity last year and pledged to continue, but analysts …
Jordan Hart
Moderna, BioNTech, and Novavax plunge after President Biden says the COVID-19 pandemic 'is over'
"The pandemic is over. We still have a problem with COVID. We're still doing a low of work on it. B…
Matthew Fox
Moderna and BioNTech stocks are surging amid reports of FDA vaccine-approval progress
Moderna and BioNTech have climbed in recent weeks as the resurgent Delta variant has captured headl…
Ethan Wu
Moderna climbs 7% as Morgan Stanley says it could fill a vaccine-demand void left by Pfizer
Morgan Stanley said on Tuesday that Moderna may provide the vast majority of COVID-19 vaccine doses…
Emily Graffeo
Moderna slides 7% even as FDA confirms vaccine's effectiveness and safety
The decline comes with Moderna's stock having surged 693% year-to-date through Monday's close.
Ben Winck
Moderna sinks 6% as investors continue to secure profits from massive vaccine rally
Moderna is awaiting FDA authorization after a panel of experts recommended the vaccine be approved …
Emily Graffeo
Moderna climbs 12% after saying its coronavirus vaccine likely protects against new strains found in the UK and South Africa
Moderna stock jumped after the biotech company said its COVID-19 vaccine can likely protect against…
Emily Graffeo
Merck sells its investment stake in Moderna after recording a 'substantial' gain
Merck initially invested $50 million in Moderna before it was public in 2015, and subsequently inve…
Matthew Fox
Pfizer and AstraZeneca slide as Moderna's rival COVID-19 vaccine shows strong efficacy
Investors may be picking sides in terms of a COVID-19 vaccine developer, as there are big differenc…
Matthew Fox
Moderna soars 10% after results show its COVID-19 vaccine is almost 95% effective
The US drugmaker said it was informed by the Data Safety Monitoring Board that its vaccine had met …
Shalini Nagarajan
Moderna soars 16% after announcing plans to file for emergency use authorization as results indicate its COVID-19 vaccine is 94% effective
Moderna said the vaccine was more than 94% effective at preventing people in its late-stage trial f…
Shalini Nagarajan
Moderna stock plummeted on Biden's support of waiving vaccine patent protections, but that backing won't have a material impact on the company, Morgan Stanley says
"Any new manufacturing operation could take 6-9 months to scale," said Morgan Stanley about compani…
Carla Mozée
Moderna slumps 11% as the vaccine-maker's Q1 revenue misses estimates
The pharma company's full-year sales forecast for its vaccine was raised to $19.2 billion, up from …
Shalini Nagarajan
Moderna surges 9% after California authorizes vaccine batch following allergy scare
State epidemiologist Dr. Erica Pan said the state found "no scientific basis to continue the pause"…
Will Daniel
The so-called reopening trade surges on Moderna vaccine trial success
The reopening trade consists of stocks that would benefit from the US economy returning to normal f…
Carmen Reinicke
Moderna surges 10% after Trump says US government reached deal for 100 million doses of its coronavirus vaccine
Moderna separately said the deal is worth $1.53 billion, and the government can purchase up to 400 …
Carmen Reinicke
Moderna skyrockets 11% after receiving additional $472 million of funding, starting phase-3 trial of COVID-19 vaccine
Moderna's total award from the Biomedical Advanced Research and Development Authority is roughly $9…
Carmen Reinicke
A California Democrat running for Congress failed to disclose investments in Moderna and Pfizer stocks
The candidate, Jay Chen, did not disclose the investments until Insider contacted his campaign with…